Inside NIA Archives: Meetings
We’re excited to be attending this meeting because it gives us here at NIA a chance to connect and re-connect with current and potential grantees. We’re hoping to see many of you at the... Read More
Every NIH institute has an executive responsible for managing its business organization. This is someone who keeps computer systems, buildings, human resources, contracts, and budget operations... Read More
We’re excited about participating in the upcoming annual meeting of the American Geriatrics Society, May 14–17 at National Harbor, just outside of Washington, DC. And, we’re hoping... Read More
I want to share with you part of a recent discussion I had with the Friends of the NIA about the importance of public-private partnerships in aging research.
Supporting... Read More
Determining the best way forward in Alzheimer’s disease research is as challenging and complicated as the disorder itself.
My dedicated staff in the Division of Neuroscience oversees and... Read More
If life begins after 40, then NIA is poised to celebrate our move into middle age!
In a special session at this year’s Gerontological Society of America (GSA) meeting in Washington, D.C., NIA... Read More
International collaboration is vital to advancing Alzheimer’s disease research on multiple fronts, from genetics to biomarkers to translational research.
Just weeks ago, at the Alzheimer’... Read More
Optimism and pessimism compete with each other as we contemplate the future for research and research funding. The prospects for important breakthroughs in NIA’s primary areas of medical... Read More
Our National Advisory Council on Aging meets three times a year to consider grant applications and programs and make recommendations, as do the Advisory Councils for the other NIH Institutes. If you... Read More
Will you join us in Bethesda, Maryland this coming October 30 and 31 to talk about aging research in a new way?
The Trans-NIH Geroscience Interest Group (GSIG), with the support of the Alliance for... Read More
It was the best of times, it was the worst of times... --Charles Dickens
These words sum up the state of Alzheimer’s disease (AD) research, specifically therapy development, over the last few... Read More